XRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil) by Falagan-Lotsch, Priscila et al.
XRCC1 gene polymorphisms in a population sample and in women
with a family history of breast cancer from Rio de Janeiro (Brazil)
Priscila Falagan-Lotsch
1, Marina S. Rodrigues
1, Viviane Esteves
2, Roberto Vieira
2, Luis C. Amendola
2,
Dante Pagnoncelli
2, Júlio C. Paixão
3 and Claudia V. De Moura Gallo
1
1Departamento de Biologia Celular e Genética, Instituto de Biologia Roberto Alcântara Gomes,
Universidade Estadual do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
2Departamento de Ginecologia, Instituto Fernandes Figueira, Fundação Oswaldo Cruz,
Rio de Janeiro, RJ, Brazil.
3Departamento de Biologia Molecular, Instituto Fernandes Figueira, Fundação Oswaldo Cruz,
Rio de Janeiro, RJ, Brazil.
Abstract
The X-ray repair cross-complementing Group1 (XRCC1) gene has been defined as essential in the base excision re-
pair (BER) and single-strand break repair processes. This gene is highly polymorphic, and the most extensively stud-
ied genetic changes are in exon 6 (Arg194Trp) and in exon 10 (Arg399Gln). These changes, in conserved protein
sites, may alter the base excision repair capacity, increasing the susceptibility to adverse health conditions, including
cancer. In the present study, we estimated the frequencies of the XRCC1 gene polymorphisms Arg194Trp and
Arg399Gln in healthy individuals and also in women at risk of breast cancer due to family history from Rio de Janeiro.
The common genotypes in both positions (194 and 399) were the most frequent in this Brazilian sample. Although
the 194Trp variant was overrepresented in women reporting familial cases of breast cancer, no statistically signifi-
cant differences concerning genotype distribution or intragenic interactions were found between this group and the
controls. Thus, in the population analyzed by us, variants Arg194Trp and Arg399Gln did not appear to have any im-
pact on breast cancer susceptibility.
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Rio de Janeiro is the Brazilian State with the highest
number of breast cancer cases: 92.77 cases/10
5 women, ac-
cordingtoINCA(2008)estimates.Manyriskfactorsarein-
volvedinbreastcancer,thegeneticcomponentbeingoneof
the most important affecting its frequency (Antoniou and
Easton, 2006). Therefore, at the population level, breast
cancer shows a high degree of familial aggregation, in
which 50% of the cases are explained by genes mainly in-
volved in maintaining genome integrity (Walsh and King,
2007). DNA damage plays a central role in carcinogenesis
and, consequently, genes involved in DNA repair are con-
sidered key genes in cancer development. The X-ray repair
cross-complementing Group1 (XRCC1) gene has been de-
fined as essential in the base excision repair (BER) and sin-
gle-strand break repair processes (Brem and Hall, 2005).
The importance of this gene is highlighted by the descrip-
tionofitsnullmutantmice,whoseembryonicdevelopment
is arrested (Tebbs et al., 1999). The XRCC1 gene codes for
a protein that is capable of interacting with different repair
proteins. More than 60 validated single-nucleotide XRCC1
polymorphisms are listed in the Ensembl database, of
which the most extensively studied are the genetic changes
in exon 6 (Arg194Trp) and in exon 10 (Arg399Gln). The
frequency of variant 194Trp is very low in Caucasians and
African Americans (5%-11%), while the frequency of vari-
ant399Glnrangesfrom32to48%inCaucasians(Huetal.,
2005). These changes in conserved protein sites may alter
the base excision repair capacity, increasing the suscepti-
bility to adverse health conditions, including cancer (Hung
et al., 2005).
In the present study, we estimated the frequencies of
Arg194Trp and Arg399Gln in the XRCC1 gene in healthy
individuals and also in women at high risk of breast cancer
due to family history (FH), from Rio de Janeiro, in order to
analyze possible differences between these groups regard-
ing the distribution of XRCC1 variants.
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Short CommunicationPeripheral blood samples were collected from 418
healthy individuals from the general population (popula-
tion sample) undergoing routine medical tests at the Pedro
Ernesto University Hospital, in the city of Rio de Janeiro,
and from 104 women participating in the “Breast Cancer
and Genetics Project – National DNA Bank” (BNDNA) of
the Fernandes Figueira Institute-FIOCRUZ, located in the
same city. This DNA bank contains genomic DNA from no
consanguineouswomenwhoreportedbreastcancerinfirst-
and/or second-degree relatives (women with a family his-
tory of breast cancer). The control group consisted of 240
individuals (72 men and 168 women) taken from the popu-
lation sample who had no reported case of breast or ovary
cancer in the family and were not affected by breast or any
other type of cancer. All the study subjects were recruited
between1996and2001,andepidemiologicaldatawereob-
tained by standardized questionnaires. Based on phenotype
characteristics, the individuals were classified into whites
and non-whites (mulattoes and blacks). Written informed
consentwasobtainedfromeachsubject.Thisstudywasap-
provedbytheEthicsCommitteesofthePedroErnestoUni-
versity Hospital and the Fernandes Figueira Institute.
Genomic DNA was prepared from the blood samples by
proteinase K digestion, according to standard methods
(Sambrook et al., 1989). Genotyping of the XRCC1 poly-
morphisms was performed as described by Deligezer and
Dalay(2004).Somerandomlyselectedsamplesweregeno-
typedbydirectsequencing(ABIPrismSequenceDetection
System – Applied Biosystems) to confirm the results. Chi-
square or Fisher’s exact test were applied to compare the
different groups with regard to genotype frequencies. Sta-
tistical analysis was performed using the GraphPad Instat 3
software (GraphPad Software, San Diego, CA); the proba-
bility level (p) of less than 0.05 was used as significance
criterion.
The characteristics of the study groups “Population
Sample” (n = 418), “Women with family history (FH) of
breast cancer” (n = 104), and “Controls” (n = 240) are pre-
sented in Table 1. The mean age of the Population Sample
was 49.7  16.4 years, and its ethnic composition was 51%
whites and 46% non-whites. All of them were inhabitants
of the metropolitan area of Rio de Janeiro for at least 6
months.ThegroupofFHwomenwasslightlyyoungerthan
the controls (mean age: 44.4  13.1 and 49.3  16.4 years,
respectively). A significant difference (p < 0.05) with re-
spect to ethnicity was observed: the number of white indi-
viduals was higher in the FH women compared to controls.
It is important to note that 57% of the women of the FH
group reported at least one first-degree relative affected by
breast cancer, about 60% of which were diagnosed before
the age of 50. Five women with a family history of breast
cancer had breast cancer themselves at the time of blood
collection. The frequency of the XRCC1 polymorphism in
thePopulationSampleispresentedinTable2,showingthat
the Arg/Arg genotypes in both positions (194 and 399)
were the most frequent. The homozygous 194Trp genotype
is extremely rare and was detected in only two individuals.
When this group was stratified by ethnicity (whites and
non-whites), we observed that the heterozygous genotype
Arg/Trp for codon 194 and the homozygous genotype
Gln/Gln for codon 399 were more prevalent in whites com-
pared to non-whites. However, these differences were not
statistically significant. Analysis of a possible intragenic
association between codon 194 and codon 399 alleles
showed that the wild-type (Arg194/Arg399) and the com-
binationofArg194and399Glnalleleswereequallydistrib-
uted in the Population Sample (43.5% and 44.0%, respec-
tively). In this analysis, we did not observe any statistically
significant difference between whites and non-whites (Ta-
ble 3). In order to evaluate the possible contribution of the
XRCC1 polymorphisms to breast cancer susceptibility, we
analyzed the genotype distribution in a group of women
with an FH of breast cancer. Thus, the frequencies were de-
terminedinthisparticulargroupandcomparedwiththege-
notype distribution observed in the controls. Since the fre-
quency of XRCC1 polymorphisms does not vary according
to gender (male x female: p = 0.80 for codon 194; p = 0.15
for codon 399), the control group was composed of both
men and women from the population sample with no previ-
ouscasesofbreastorovarycancerinthefamily.Thedistri-
bution of XRCC1 polymorphisms was similar in both
groups, although women with an FH of breast cancer
showed a higher percentage of genotypes presenting the
Trip allele (Arg/Trp + Trp/Trp) than the controls (19.3%
and 13.3%, respectively). This difference was more notice-
ablewhenweconsideredonlywomenreportingatleastone
affected first-degree relative: 22% x 13.3% in controls. On
the other hand, the Gln allele for codon 399 was more fre-
quent in the control group. However, these differences
were not statistically significant (Table 4). Women report-
ing only second-degree relatives affected by breast cancer
showed a similar genotype distribution and allele frequen-
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Table 1 - Descriptive characteristics of the population sample, women
with family history (FH) of breast cancer and controls.
Characteristics Population sample
(n = 418)
Women with
FH (n = 104)
Control
(n = 240)
Age (years) 49.7  16.4 44.4  13.1 49.3  16.2
Ethnicity, n (%)
Whites 214 (51.0) 65 (62.0) 122 (51.0)
Non-whites 190 (46.0) 35 (34.0) 118 (49.0)
Missing data 14 (3.0) 4 (4.0) 0
Classification by degree of affected relatives
1, n (%)
First 59 (57.0)
Second 45 (43.0)
1First-degree relative: at least one first-degree relative affected by breast
cancer; second- degree: at least one second-degree relative affected by
breast cancer and no affected first-degree relative.cies for both XRCC1 variants compared to the control
group. In the ethnicity analysis, the distribution of poly-
morphisms Arg194Trp and Arg399Gln in women with FH
and in controls was similar in whites and non-whites
(whites: p = 0.08 for codon 194; p = 0.44 for codon 399;
non-whites: p = 1.00 for codon 194; p = 0.34 for codon
399).Theintragenicassociationstudydidnotshowanysta-
tisticallysignificantdifferenceconcerningthefrequencyof
a particular genotype combination for both polymorphic
variants when women with an affected first-degree relative
and controls were compared (194Trp/Arg399: p = 0.49;
Arg194/399Gln:p=0.33;194Trp/399Gln:p=0.26.Refer-
ence: Arg194/Arg399). All genotype distributions of the
XRCC1 gene were in Hardy-Weinberg equilibrium.
The XRCC1 protein is considered an essential part of
boththesingle-strandbreakrepairandthebaseexcisionre-
pair systems (Cappelli et al., 1997). Here, we studied two
XRCC1polymorphisms:Arg194Trp,locatedinexon6,and
Arg399Gln, located in exon 10. Both substitutions pro-
duced structural changes in the protein molecule, probably
altering its biological activity and consequently affecting
the DNA repair efficiency. These observations led us to re-
alize the importance of determining the distribution of
these genetic variants in our population. Brazil has a large
territory and the differences in colonization among differ-
ent geographical regions resulted in different levels of mis-
cegenation (Alves-Silva et al., 2000). So far, four papers
have described the XRCC1 genotype distribution in Brazil-
ian populations, all of them from the State of São Paulo
(Rossit et al., 2002; Duarte et al., 2005; Dufloth et al.,
2005; Canalle et al., 2006). The distribution of both poly-
morphisms found by us in a population sample from Rio de
Janeiro was similar to that found in São Paulo, the wild-
type genotypes being the most frequent. Concerning eth-
nicity, the allele frequency for the 194Trp variant in Euro-
descendents (whites) from Rio de Janeiro was 0.08 and in
Afro-descendents (non-whites) 0.06 (Table 2). These re-
sultsareinagreementwiththoseobservedinAmericanand
European Caucasians (0.05-0.09) and in African Ameri-
cans (0.05-0.11) (Lunn et al., 1999; David-Beabes and
London, 2001; Smith et al., 2003; Hu et al., 2005;
Pachkowski et al., 2006). The frequency of the 399Gln
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Table 2 - Frequency of polymorphisms XRCC1-Arg194Trp and XRCC1-Arg399Gln in the population sample and distribution according to ethnicity.
Genotype XRCC1
1 Population sample (n = 418) n (%) White (n = 214) n (%) Non-White (n = 190) n (%) p-value
2
Arg194Trp
Arg/Arg 366 (87.6) 182 (85.0) 170 (89.5)
Arg/Trp 50 (12.0) 31 (14.5) 19 (10.0)
Trp/Trp 2 (0.5) 1 (0.5) 1 (0.5)
Arg/Trp + Trp/Trp 52 (12.5) 32 (15.0) 20 (10.5) 0.23
Trp-allele frequency 0.07 0.08 0.06
Arg399Gln
Arg/Arg 223 (53.4) 109 (50.9) 106 (55.8)
Arg/Gln 159 (38.0) 82 (38.3) 73 (38.4)
Gln/Gln 36 (8.6) 23 (10.8) 11 (5.8) 0.18
Arg/Gln + Gln/Gln 195 (46.6) 105 (49.1) 84 (44.2)
Gln-allele frequency 0.28 0.30 0.25
1Missing data - 14 (3.3%) individuals of the population sample could not be classified according to ethnic group.
2Chi-square or Fisher’s exact test.
Table 3 - Intragenic association of the XRCC1 polymorphisms (Population sample).
Exon 6 Codon 194 Exon 10 Codon 399 Population sample n (%) White n (%) Non-White n (%) p-Value
1
All wild-type genotypes
Arg Arg 182 (43.5) 84 (39.3) 90 (47.4)
One variant polymorphism
Trp Arg 41 (9.8) 25 (11.7) 16 (8.4) 0.17
Arg Gln 184 (44.0) 98 (45.8) 80 (42.1) 0.24
Two variant polymorphisms
Trp Gln 11 (2.7) 7 (3.2) 4 (2.1) 0.36
1Fisher’s exact test (the wild-type genotypes were used as reference).variant allele was of 0.30 in Brazilians of European de-
scent, quite similar to the frequencies reported for Ameri-
can Caucasians (0.32-0.37) and European Caucasians
(0.32-0.48) (Lunn et al., 1999; David-Beabes and London,
2001; Matullo et al., 2001; Duell et al., 2002; Smith et al.,
2003; Hu et al., 2005; Pachkowski et al., 2006). In the Bra-
zilians of African descent, the frequency of the 399Gln al-
lelewas0.25,aboutthesame(0.27)asobservedbyCanalle
et al. (2006) for Afro-descendents from São Paulo (Brazil),
but higher than that observed in African Americans
(0.14-0.18) (Lunn et al., 1999; David-Beabes and London,
2001; Duell et al., 2002; Hu et al., 2005; Pachkowski et al.,
2006). The intragenic association analysis showed that the
most frequent combinations were the wild-type
Arg194/Arg399 and the genotype with one variant
Arg194/399Gln (43.5% and 44.0%, respectively), reveal-
ing the high frequency of the Gln allele in the Brazilian
population. It remains, however, to be clarified which are
the reasons why the State of Rio de Janeiro is the one with
the highest number of breast cancer cases in Brazil. Family
aggregation of this disease is also largely observed, which
led us to search for clues about genetic susceptibility. Al-
though hereditary breast cancer is commonly associated
with high-penetrance genes such as BRCA1/2 and TP53
(Walsh et al., 2006), a clear risk genotype for the most part
of the breast cancer families has not yet been described
(Antoniou and Easton, 2006). In an approach distinct from
the classical case-control association studies, we compared
the distribution of the most studied variants of the XRCC1
gene in women reporting FH of breast cancer with the dis-
tribution in individuals without reported breast cancer
cases in the family (controls). No statistical differences
were observed in the genotype distributions or in the intra-
genic interactions of polymorphisms Arg194Trp and
Arg399Gln. So, according to our data, these XRCC1 gene
variants do not appear to have any impact on breast cancer
susceptibility in the analyzed population. To elucidate the
role of XRCC1 variants and cancer risk, several case-
control studies have been conducted, but the results are in-
consistent. Two meta-analysis studies described the
194Trp variant as being related to a decrease in cancer risk
(Goode et al., 2002; Hu et al., 2005), but Chacko et al.
(2005) observed an association between allele 194Trp and
the risk of breast cancer in women from India. However, a
recent meta-analysis performed with a large number of
cases from the United States (Zhang et al., 2006) did not
find any relation between the presence of either the XRCC1
Arg194Trp or the Arg399Gln polymorphisms, among
other DNA repair genes, and risk of breast cancer. Repair
genes are unequivocally important in the process of breast
cancer susceptibility but, as several repair systems may
superpose and act together, a clear picture in case-control
studies is very difficult to achieve. In spite of our limited
sample size, we found the same trend described in previous
studies on breast cancer patients with an FH (Smith et al.,
2003;Duflothetal.,2005;Costaetal.,2007).Furtherstud-
ies with larger samples are needed to elucidate the role of
these XRCC1 gene variants in the genetic susceptibility to
breast cancer.
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Table 4 - Allele and genotype frequencies of polymorphisms XRCC1-Arg194Trp and XRCC1-Arg399Gln in women reporting a family history (FH) of
breast cancer in first-degree relatives and controls.
Genotype XRCC1 Women with FH in first-degree relatives n (%) Controls n (%) OR (95%CI)
1
Arg194Trp
Arg/Arg 46 (78.0) 208 (86.6) 1.0 (reference)
Arg/Trp 12 (20.3) 32 (13.4) 1.70 (0.81-3.54)
Trp/Trp 1 (1.7) 0 ND
2
Arg/Trp + Trp/Trp 13 (22.0) 32 (13.3) 1.84 (0.89-3.77)
Trp allele frequency 0.12 0.07
Arg399Gln
Arg/Arg 33 (55.9) 120 (48.8) 1.0 (reference)
Arg/Gln 25 (42.4) 103 (41.9) 0.88 (0.49-1.58)
Gln/Gln 1 (1.7) 23 (9.3) 0.16 (0.02-1.22)
Arg/Gln + Gln/Gln 26 (44.1) 126 (51.2) 0.75 (0.42-1.33)
Gln allele frequency 0.23 0.30
1Fisher’s exact test.
2ND not determined due to small sample size in the category.References
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